ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife
India Drug Delivery Devices Market 2024, With Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma
T2 Biosystems Announces Plans to License Its Proprietary Technology to Expand Its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
Express News | Cardinal Health Inc - Enters Into Term Loan Credit Agreement
Cardinal Health Awarded $9B Defense Logistics Agency Contract Modification
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $149
Baird Adjusts Cardinal Health Price Target to $149 From $145, Maintains Outperform Rating
Cardinal Health's (NYSE:CAH) Investors Will Be Pleased With Their Splendid 174% Return Over the Last Three Years
PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins
Cardinal Health Stock Soars to All-time High of $126.15
Express News | FDA: Recall of Some Insulin Syringe Luer-Lock by Cardinal Health Due to Incompatibility With Needleless IV Connectors
Express News | FDA: Cardinal Health Removes Some Monoject U-100 Ml Insulin Syringe Luer Lock With Tip Cap Soft Packs - Website
Express News | Cardinal Health Inc : Mizuho Assumes Coverage With Outperform Rating; Price Target $139
Coregistics Announces New Senior Leadership Team, Including Victor Crawford as Executive Chairman
Cardinal Health, Inc. (CAH) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
Cardinal Health, Inc. (CAH) Citi's 2024 Global Healthcare Conference (Transcript)
Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform -- Barrons.com
Insiders At Cardinal Health Sold US$18m In Stock, Alluding To Potential Weakness
Should Value Investors Buy Cardinal Health (CAH) Stock?
Trump has promised to significantly reduce corporate taxes! Who are the potential big winners of the tax cuts?
JPMorgan pointed out that companies in the S&P 500 index with an actual tax rate greater than 15% and 80% of revenue coming from the USA are potential beneficiaries of Trump's tax cuts policy, mainly concentrated in the financial and industrial sectors, followed by essential consumer, optional consumer, and medical care sectors.